Videos

July Highlight: Updated Guideline Recommendations for VMAT Inhibitor Use

07/29/2021

Popular Now

News

FDA Approves ABILIFY ASIMTUFII for Schizophrenia and Bipolar Disorder Treatment

04/28/2023

The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder.

The FDA approved ABILIFY...

04/28/2023

Psych Congress Network

Podcasts

New Mechanisms of Action in Psychiatry With Dr Craig Chepke

09/14/2022

In this podcast excerpt, Craig Chepke, MD, FAPA, psychiatrist and medical director at Excel Psychiatric Associates in Huntersville, North Carolina, discusses the new mechanisms of action (MOAs) that could help to improve patient care in the...

In this podcast excerpt, Craig...

09/14/2022

Psych Congress Network

Podcasts

Digital Mental Health Encompasses More Than Telehealth

11/10/2021

Steven R Chan, MD, MBA, and Gowri Aragam, MD, sat down at the recent 2021 Psych Congress to discuss the current and future landscape of digital mental health (DMH).

Steven R Chan, MD, MBA,...

11/10/2021

Psych Congress Network

Videos

Goal of Holistic Care With Remote Monitoring and Telehealth Integration

04/14/2022

Shyam B. Paryani, MD, MD, MHA, FACRO, FACHE, explains the connection between telehealth, digital mental health, and clinical intervention to keep patients healthy.

Shyam B. Paryani, MD, MD, MHA,...

04/14/2022

Psych Congress Network

News

Hormonal Contraception-Associated Depressive Episodes May Be Linked to PPD Risk

07/14/2023

Meagan Thistle

Depression associated with hormonal contraception (HC) use may indicate susceptibility to postpartum depression (PPD), linking depressive episodes with hormonal contributions, findings published in JAMA Psychiatry suggest.

July Highlight: Updated Guideline Recommendations for VMAT Inhibitor Use

Popular Now

Sign Up

Specialties

Events

Year Round Education

HMP Global Products